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ABSTRACT 
Medicinal plants have been widely used to treat a variety of infectious and 
non-infectious diseases. According to an estimate, 25% of the commonly used 
medicines contain compounds isolated from plants. Several plants could offer a rich 
reserve for drug discovery of infectious diseases, particularly in an era when the latest 
separation techniques are available on one hand, and the human population is 
challenged by a number of emerging infectious diseases on the other hand. Among 
several other ailments, fungal infections are posing a great threat to the mankind, as a 
large number of people suffer from fungal infections worldwide due to emerging 
resistance of fungal strains. The available antifungal drugs are either too costly or are 
accompanied with several side effects. Of importance, a variety of medicinal plants 
have shown promise to treat a number of fungal infections, and some of them possess 
broad-spectrum antifungal activity. This article describes potential antifungal 
properties of medicinal plants against fungi, and suggests screening the potential of 
plants possessing broad-spectrum antifungal effects against emerging fungal 
infections. 
Keywords: Medicinal Plants, Conventional medicine, fungal infection, antifungal. 
INTRODUCTION 
Fungal infections are the 
leading cause of death in both 
advanced and developing countries. 
This is due to the use of 
immunosuppressive treatments, long 
term use of antibiotics, and longer 
survival of immunocompromised 
individuals (Molero et al., 1998). 
There are numerous antifungal 
agents used clinically to treat fungal 
infections. Triazole antifungal agents 
like fluconazole and itraconazole came 
into play in the early 1990’s, followed 
by amphotericin-B in the mid 1990’s. 
These antifungal drugs can be broadly 
classified into five major classes, i.e. 
azoles, allylamines, echinocandins, 
griseofulvin, and flucytosine (Chen 
and Sorrell, 2007). 
The emerging resistance of 
microbes to antifungal agents has 
serious implications in the 
management of infections. These 
antifungal compounds also act on 
targets found in mammalian cells 
which may result in toxicity or adverse 
drug interactions (Lucca and Walsh, 
1999). Ketoconazole is one of the 
antifungal drugs used against both 
superficial and deep seated infections. 
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However, its unpleasant side effects 
include nausea, abdominal pain, 
itching, toxicity, slow therapeutic 
response, and poor efficacy in 
immunocompromised patients (Pyun 
and Shin, 2005). 
Therefore, the discovery of 
novel antifungals is severely needed. 
Phytochemistry of various plant 
species has indicated that the 
phytochemicals could be a better 
source of medicine as compared to 
synthetically produced drugs. The use 
of plants as medicine goes back to 
early man. These traditional medicines 
based on medicinal plants have been 
used for centuries. Therefore one 
approach that has been used for 
discovery of antimicrobial agents is the 
evaluation of plant extracts (Ozcelic et 
al., 2005).  
Medicinal plants are of great 
importance to health of individuals and 
communities. This importance lies in 
their chemical substances that produce 
a definite physiological action on the 
human body. The most important of 
these bioactive compounds include 
alkaloids, tannins, flavonoids, and 
phenolic compounds (Edeoga et al., 
2005).  The health effects of flavonoids 
include antioxidant, anti-inflammatory, 
antiallergic, hepatoprotective, 
antithrombotic, antiviral, and anti-
carcinogenic (Prior, 2003). Alkaloids 
show many useful effects like anti-
hypertensive and anti-tumor. Alkaloid 
based drugs include caffeine, quinine, 
nicotine, artemisinin, cholchicine, and 
amblyopia (Taber et al., 2002). 
Tannins include corilagin and geraniin, 
which show anti-human immuno 
deficiency syndrome activity by 
inhibiting reverse transcriptase (Notka 
et al., 2004). 
Emerging Fungal Pathogens 
Fungal pathogens are a leading 
cause of morbidity and mortality in 
immunocompromised patients. Several 
of these pathogens are well known, e.g. 
Aspergillus fumigatus. Aspergillus 
fumigatus is the major cause of 
nosocomial fungal pneumonia and is 
the cause of the second most common 
fungal infections. The antifungal drug 
Azole was effective against this 
pathogen but now it has started 
developing a resistance against it 
(Moye-rowley, 2015). Fungal keratitis, 
an infection of the cornea, is caused by 
a rare Trichophyton spp. (Sharma et 
al., 2014). Cryptococcus neoformans is 
the cause of CNS mycosis in HIV-
infected patients (Price et al., 2011). 
Histoplasma capsulatum causes a rare 
infection, Histoplasmosis, which 
typically targets mammals. It has a 
latent stage can be reactivated when 
the patient is immunocompromised 
(Rappleye et al., 2004). There is also 
recognition of other emerging fungal 
infections, such as Fusarium spp, 
Zygomycetes and dematiaceous 
moulds, dimorphic fungi such as 
Penicillium marneffei, Coccidioides 
inmotis, and Histoplasma capsulatum 
(Walsh and Groll, 1999).  
Candida spp. has been found to 
be fourth leading cause of nosocomial 
infections (Pfaller and Diekema, 
2007). They caused about 88% of 
infections in the United States between 
1980 and 1990. Candida albicans is 
the species most commonly isolated 
from clinical material and accounts for 
40-70 % of cases of candidiasis. The 
epidemiology data indicates that 5 to 
10 of every 1000 risk patients will 
contract Candida blood stream 
infection and about 35 % of these 
patients will die as a result of infection, 
while 30 % will die as a result of an 
underlying disease (Lockhart et al., 
2009). In 2013, it was reported by the 
Centers for Disease Control (CDC) in 
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the United States that a resistant strain 
of Candida albicans is responsible for 
approximately 3,400 cases of both 
superficial and blood stream infections, 
annually. 
In addition to humans, plants 
are also greatly affected by different 
fungal infections. Puccinia spp. causes 
different types of rust diseases in 
wheat and is a reason for great losses 
in grain production (McIntosh et al., 
1995). Fusarium graminearum causes 
a disease called Fusarium head blight 
in wheat and barley (Ding et al., 2009). 
Alternaria species is among the most 
common cause of necrotrophic 
diseases of plants. Some of the major 
plant pathogens reside in this genus, 
including A. brassicicola and A. solani. 
A. brassicicola is the cause of black 
spot disease on an important plant 
species of Brassica (Westman et al., 
1999). Synchytrium endobioticum, a 
soil-borne obligate biotrophic fungus, 
is the cause of potato wart disease in 
the cultivated potato (Solanum 
tuberosum L.) (Obidiegwu et al., 2014) 
Ustilago maydis is a member of 
the biotrophic smut fungi that infects 
grasses and many important crop 
plants such as maize, wheat, barley, 
and sugar cane (Brefort et al., 2009). 
Medicinal Values of Plants 
The recent research on 
medicinal plants has revealed their 
great pharmacological importance due 
to the presence of active 
phytoconstituents. Medicinal 
substances are products of metabolic 
pathways. Nevertheless, each species 
has its own genetic structure that 
governs the presence of bioactive 
molecules. Environmental effects are 
also responsible for variations in the 
amount of phytochemicals present in 
each species (Thomas, 2000). 
About 80% of the world 
depends on alternative medicines from 
plants. Approximately 70, 000 plants 
are used in medicines. Indian 
Ayurveda utilizes about 2,000 plants to 
cure different ailments. These plants 
are our common heritage and their use 
for human use has developed the 
concept of herbal medicine or 
phytotherapy. Every medicinal herb 
contains a number of constituents that 
facilitate its curative activity. A few of 
these compounds include reserpine, 
taxol, and vincristine, which have been 
isolated and synthesized on a large 
scale. The total number of compounds 
present in the plant kingdom is about 
200, 000. These compounds are used 
by plants for maintenance, 
reproduction, healing, defense, and 
offense. The plants are used for their 
nutrients in general, and to some extent 
for the healing process. Many of these 
food plants possess polyphenols and 
antioxidants. Vegetable, fruits and nuts 
are also a good source of secondary 
metabolites (Daniel, 2006). A 
summary of medicinal plants having 
antifungal effects have been given in 
table 1. 
Isolation and Characterization of 
Antifungal Compounds 
The very basic and essential 
step for the evaluation of therapeutic 
potential of medicinal plants is 
preparation of a crude extract, 
followed by isolation of various 
medicinal constituents. There are a 
large number of books and literature 
available regarding phytomedicines. 
Some examples are Plant Drug 
Analysis: A Thin Layer 
Chromatography Atlas (Wagner et al., 
1996), Modern Phytomedicine: 
Turning Medicinal Plants into Drugs 
(Ahmad et al., 2007) and Laboratory 
Handbook for the Fractionation of 
Natural Extracts (Houghton and 
Murtaza et al.,: Antifungal Potentials of Medicinal Plants 
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Table 1: Medicinal Plants used against different pathogenic fungi. 
 Medicinal Plants Antifungal activity References 
1.  Eucalyptus globolus, 
Punica granatum, 
Artemisia mexcana and 
Bocconia arborea 
The methanolic plant extracts possess strong in vitro 
anticandidal activity 
Navarro et al. 1996 
2.  Micromeria nervosa and 
Inula viscose 
Ethanolic and aq. extracts were tested and show antifungal 
activity  
Ali-Shtayeh et al. 
1998 
3.  Hypericum scabum, 
Thymus fallax 
Trichloromethanolic, n-hexane, aqueous aerial parts, bulb 
and seed of plants show anticandidal activity. 
Atalay et al. 1999 
4.  Rhoicissus digitata and 
Rhoicissus rhomboidea 
Methanolic extract of root exhibited highest anticandidal 
activity. 
Lin et al. 1999 
5.  Albiizia lebbeck, Allium 






Tectona grandis and 
Zingiber officinale 
Aqueous extracts of plants used to cure Candidiasis. Srinivasan et al. 
2001 
6.  Rubus ulmifolius Methanolic extract of leaves, branches and flowering tops 
showed a larger inhibition zone against Candida albicans. 
Panizzi et al. 2002 
7.  Terminalia chebula Methanolic and aqueous extract of seed of plant show 
anticandidal activity 
Vonshak et al. 2003 
8.  Syzygium jambolanum Leaf, fruit, stem, bark showed anticandidal activity. Chandraekaran et 
al. 2004 
9.  Zanthoxylum 
americanum 
Aqueous extracts show antifungal activity Bafi-Yeboa et al. 
2005 
10.  Justicia secunda and 
Piper pulchrum 
Methanolic extract of plant show anticandidal activity Rojas et al. 2006 
11.  Schinus terebintifolis, 
Ocimum gratissimum, 
Cajanus cajan and 
Piper aduncum 
Methanolic extracts of different parts show anticandidal 
activity.  
Braga et al. 2007 
12.  Piper ovatum Vahl C. tropicalis Silva et al., 2009 
13.  Mentha piperita Antifungal activities against Candida and Aspergillus spp. Saharkhiz et al., 
2012 
14.  Achillea millefolium Anticandidal activity Ribeiro et al., 2010 
15.  Cymbopogon citratus Antifungal activity against Malassezia spp. Carmo et al., 2013 
16.  Boesenbergia pandurata Antifungal activity against Candida albicans  Taweechaisupapon
g et al., 2010 
17.  Xanthium strumarium L. Essential oil inhibits growth of Candida albicans and 
Aspergillus niger 
Rad et al., 2015 
18.  Oxalis corniculata crude, n-hexane, and chloroform extracts show activity 
against Fusarium solani, Aspergillus flexneri, and 
Aspergillus flavus 
Rehman et al., 2015 
19.  Polyscias fulva ethyl acetate, n-butanol and residue showed activity 
against different  Candida species and 
Njateng et al., 2015 
Murtaza et al.,: Antifungal Potentials of Medicinal Plants 
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Raman, 1998). Most of the books 
describe classical procedures which 
pose limitations of reproducibility and 
quality.  To ensure high quality herbal 
preparations, efforts are ongoing to 
replace traditional methodologies with 
modern sample preparation and 
extraction procedures. Classical 
methods are being complemented with 
modern techniques like microwave-
assisted extraction, pressurized liquid 
extraction, matrix-assisted laser 
desorption/ionization mass 
spectrometry, and several others 
(Mukhtar et al. 2008). 
Future Prospects  
The importance of plants is 
becoming clear from the fact that more 
than 80% of the world population 
fulfills its medical needs from plants. 
There is a need of collaborative steps 
to make usage of medicinal plants 
common. The habitats which are rich 
in treasure of medicinal plants should 
be focused on. This would not only 
uplift the economy of the poor 
inhabitants, but also lead to preparation 
of medicines indigenously. The 
discovery of active principles from 
plants with the help of the developed 
world could also eliminate the 
emerging resistance of fungi to the 
synthetic drugs.  
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